BD to Present at Wells Fargo 2024 Healthcare Conference

Rhea-AI Summary

BD (Becton, Dickinson and Company), a leading global medical technology company, has announced its participation in the Wells Fargo 2024 Healthcare Conference. The presentation is scheduled for Wednesday, September 4, 2024, at 8:45 am Eastern Time.

Investors and interested parties can access the live webcast of BD's presentation through the company's investor relations website at investors.bd.com. For those unable to attend the live event, a replay will be made available on the same webpage after the presentation concludes.

This conference provides BD with an opportunity to showcase its latest developments and strategies to investors and industry professionals. The company's participation underscores its commitment to transparency and engagement with the financial community.

FRANKLIN LAKES, N.J., Aug. 8, 2024 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that it will present at the Wells Fargo 2024 Healthcare Conference on Wednesday, September 4, 2024 at 8:45 am Eastern Time.

The live webcast of BD's presentation can be accessed from the BD investor relations website, investors.bd.com. A replay of the event will be available on the same webpage following its conclusion.

About BD
BD is one of the largest global medical technology companies in the world and is advancing the world of health by improving medical discovery, diagnostics and the delivery of care. The company supports the heroes on the frontlines of health care by developing innovative technology, services and solutions that help advance both clinical therapy for patients and clinical process for health care providers. BD and its more than 70,000 employees have a passion and commitment to help enhance the safety and efficiency of clinicians' care delivery process, enable laboratory scientists to accurately detect disease and advance researchers' capabilities to develop the next generation of diagnostics and therapeutics. BD has a presence in virtually every country and partners with organizations around the world to address some of the most challenging global health issues. By working in close collaboration with customers, BD can help enhance outcomes, lower costs, increase efficiencies, improve safety and expand access to health care. For more information on BD, please visit bd.com or connect with us on LinkedIn at www.linkedin.com/company/bd1/ and Twitter @BDandCo.

Contacts:
Media:	Investors:
Troy Kirkpatrick	Adam Reiffe
VP, Public Relations	Sr. Director, Investor Relations
858.617.2361	201.847.6927
troy.kirkpatrick@bd.com	adam.reiffe@bd.com

 

View original content:https://www.prnewswire.com/news-releases/bd-to-present-at-wells-fargo-2024-healthcare-conference-302218247.html

SOURCE BD (Becton, Dickinson and Company)

FAQ

When is BD (BDX) presenting at the Wells Fargo 2024 Healthcare Conference?

BD (BDX) is presenting at the Wells Fargo 2024 Healthcare Conference on Wednesday, September 4, 2024, at 8:45 am Eastern Time.

How can I watch BD's (BDX) presentation at the Wells Fargo 2024 Healthcare Conference?

You can watch BD's (BDX) presentation via a live webcast accessible from the company's investor relations website at investors.bd.com.

Will there be a replay available of BD's (BDX) presentation at the Wells Fargo conference?

Yes, a replay of BD's (BDX) presentation at the Wells Fargo 2024 Healthcare Conference will be available on the company's investor relations website after the event concludes.

What is the stock symbol for BD mentioned in the press release?

The stock symbol for BD (Becton, Dickinson and Company) mentioned in the press release is BDX, listed on the New York Stock Exchange (NYSE).